208 related articles for article (PubMed ID: 20010160)
1. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
2. [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma].
Berger C; Dimant P; Hermida L; Paulin F; Pereyra M; Tejo M
Medicina (B Aires); 2012; 72(5):425-7. PubMed ID: 23089120
[TBL] [Abstract][Full Text] [Related]
3. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
[No Abstract] [Full Text] [Related]
6. Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
Solipuram V; Baretti M; Kim AY; Chen LX; Fahrner JA; Gunay-Aygun M; Peng XP; Hardenbergh D; Ferguson A; Griffith P; Wang Y; Brancati M; Gopalakrishna H; Kato T; Shubert C; Laheru D; Yarchoan M
Hepatology; 2021 Nov; 74(5):2899-2901. PubMed ID: 34105830
[No Abstract] [Full Text] [Related]
7. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis.
Kakar S; Burgart LJ; Batts KP; Garcia J; Jain D; Ferrell LD
Mod Pathol; 2005 Nov; 18(11):1417-23. PubMed ID: 15920538
[TBL] [Abstract][Full Text] [Related]
8. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
[TBL] [Abstract][Full Text] [Related]
9. Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma.
Levin SN; Tomasini MD; Knox J; Shirani M; Shebl B; Requena D; Clark J; Heissel S; Alwaseem H; Surjan R; Lahasky R; Molina H; Torbenson MS; Lyons B; Migler RD; Coffino P; Simon SM
Sci Adv; 2023 Jun; 9(25):eadg7038. PubMed ID: 37343102
[TBL] [Abstract][Full Text] [Related]
10. Liver resection in advanced hepatocellular carcinoma.
Usatoff V; Isla AM; Habib NA
Hepatogastroenterology; 2001; 48(37):46-50. PubMed ID: 11268996
[TBL] [Abstract][Full Text] [Related]
11. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Chan JS; Harding CO; Blanke CD
South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
[TBL] [Abstract][Full Text] [Related]
12. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
[TBL] [Abstract][Full Text] [Related]
13. Fibrolamellar hepatocellular carcinoma presenting as cholestatic jaundice: An unusual presentation of a rare disease.
Singh A; Goyal S; Mehta V; Kakkar C; Narang V; Sood A
Indian J Pathol Microbiol; 2023; 66(2):385-387. PubMed ID: 37077092
[TBL] [Abstract][Full Text] [Related]
14. Resection of a fibrolamellar carcinoma of the liver originating in the caudate lobe.
Machado MC; Herman P; Bacchella T; Pugliese V; Pinotti HW
Hepatogastroenterology; 1995; 42(6):993-5. PubMed ID: 8847058
[TBL] [Abstract][Full Text] [Related]
15. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma with fibrolamellar pattern in a patient with autoimmune cholangitis.
Singson RC; Fraiman M; Geller SA
Mt Sinai J Med; 1999 Mar; 66(2):109-12. PubMed ID: 10100415
[TBL] [Abstract][Full Text] [Related]
17. [Fibrolamellar hepatocellular carcinoma: a clinical report with paraneoplastic hyperthyroidism (apropos of a case)].
Carri J; Peral F; Surreco M; Luján A; Leguizamón R; Martínez G; Salvucci M
Acta Gastroenterol Latinoam; 1989; 19(3):155-64. PubMed ID: 2561432
[TBL] [Abstract][Full Text] [Related]
18. Encephaloradiculopathy: a non-metastatic complication of hepatocellular carcinoma.
Phanthumchinda K; Rungruxsirivorn S
J Med Assoc Thai; 1991 May; 74(5):288-91. PubMed ID: 1664447
[TBL] [Abstract][Full Text] [Related]
19. Fibrolamellar hepatocellular carcinoma in an infant and literature review.
Cruz O; Laguna A; Vancells M; Krauel L; Medina M; Mora J
J Pediatr Hematol Oncol; 2008 Dec; 30(12):968-71. PubMed ID: 19131794
[TBL] [Abstract][Full Text] [Related]
20. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
